Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)

CAPS Rating: 4 out of 5

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories.

Recs

0
Player Avatar larvalbug (60.50) Submitted: 9/20/2013 11:12:51 PM : Outperform Start Price: $37.45 TEVA Score: +21.61

Nice yield. Excellent long-term cash flow growth. Low risk. Reasonably good financial strength. Low debt. Low forward P/E. Good ratios of EV/EBITDA and gross income to total assets. Major holdings by value mutual funds.

Featured Broker Partners


Advertisement